RAE1ε Ligand Expressed on Pancreatic Islets Recruits NKG2D Receptor-Expressing Cytotoxic T Cells Independent of T Cell Receptor Recognition

Immunity

Volumn 36, Issue 1, 2012, Pages 132-141

  Markiewicz, Mary A ^a   Wise, Erica L ^a   Buchwald, Zachary S ^a   Pinto, Amelia K ^a   Zafirova, Biljana ^b   Polic, Bojan ^b   Shaw, Andrey S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

NATURAL KILLER CELL RECEPTOR NKG2D; RANTES; RETINOIC ACID; RETINOIC ACID EARLY TRANSCRIPT 1 EPSILON; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN DETECTION; ARTICLE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EMBRYONIC STEM CELL; ENZYME ACTIVITY; IN VITRO STUDY; INSULITIS; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

ANIMALS; CELL MOVEMENT; FLOW CYTOMETRY; ISLETS OF LANGERHANS; LIGANDS; MICE; MICE, TRANSGENIC; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, CYTOTOXIC; TRETINOIN;

EID: 84856244046     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2011.11.014     Document Type: Article

References (53)

1. Appay V., Rowland-Jones S.L. RANTES: a versatile and controversial chemokine. Trends Immunol. 2001, 22:83-87.
2. Bacon L., Eagle R.A., Meyer M., Easom N., Young N.T., Trowsdale J. Two human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D. J.Immunol. 2004, 173:1078-1084.
3. Bauer S., Groh V., Wu J., Steinle A., Phillips J.H., Lanier L.L., Spies T. Activation of NK cells and Tcells by NKG2D, a receptor for stress-inducible MICA. Science 1999, 285:727-729.
4. Carayannopoulos L.N., Naidenko O.V., Fremont D.H., Yokoyama W.M. Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D. J.Immunol. 2002, 169:4079-4083.
5. Carayannopoulos L.N., Naidenko O.V., Kinder J., Ho E.L., Fremont D.H., Yokoyama W.M. Ligands for murine NKG2D display heterogeneous binding behavior. Eur. J. Immunol. 2002, 32:597-605.
6. Cemerski S., Das J., Locasale J., Arnold P., Giurisato E., Markiewicz M.A., Fremont D., Allen P.M., Chakraborty A.K., Shaw A.S. The stimulatory potency of Tcell antigens is influenced by the formation of the immunological synapse. Immunity 2007, 26:345-355.
7. Cerwenka A., Bakker A.B., McClanahan T., Wagner J., Wu J., Phillips J.H., Lanier L.L. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 2000, 12:721-727.
8. Chalupny N.J., Sutherland C.L., Lawrence W.A., Rein-Weston A., Cosman D. ULBP4 is a novel ligand for human NKG2D. Biochem. Biophys. Res. Commun. 2003, 305:129-135.
9. Champsaur M., Lanier L.L. Effect of NKG2D ligand expression on host immune responses. Immunol. Rev. 2010, 235:267-285.
10. Cosman D., Müllberg J., Sutherland C.L., Chin W., Armitage R., Fanslow W., Kubin M., Chalupny N.J. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 2001, 14:123-133.
11. Coudert J.D., Scarpellino L., Gros F., Vivier E., Held W. Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways. Blood 2008, 111:3571-3578.
12. Dai Z., Turtle C.J., Booth G.C., Riddell S.R., Gooley T.A., Stevens A.M., Spies T., Groh V. Normally occurring NKG2D+CD4+ Tcells are immunosuppressive and inversely correlated with disease activity in juvenile-onset lupus. J.Exp. Med. 2009, 206:793-805.
13. Denucci C.C., Mitchell J.S., Shimizu Y. Integrin function in T-cell homing to lymphoid and nonlymphoid sites: getting there and staying there. Crit. Rev. Immunol. 2009, 29:87-109.
14. Diefenbach A., Jamieson A.M., Liu S.D., Shastri N., Raulet D.H. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 2000, 1:119-126.
15. Diefenbach A., Hsia J.K., Hsiung M.Y., Raulet D.H. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity. Eur. J. Immunol. 2003, 33:381-391.
16. Ehrlich L.I., Ogasawara K., Hamerman J.A., Takaki R., Zingoni A., Allison J.P., Lanier L.L. Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8+ Tcells. J.Immunol. 2005, 174:1922-1931.
17. Finegood D.T., Scaglia L., Bonner-Weir S. Dynamics of beta-cell mass in the growing rat pancreas. Estimation with a simple mathematical model. Diabetes 1995, 44:249-256.
18. Gilfillan S., Ho E.L., Cella M., Yokoyama W.M., Colonna M. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation. Nat. Immunol. 2002, 3:1150-1155.
19. Groh V., Rhinehart R., Randolph-Habecker J., Topp M.S., Riddell S.R., Spies T. Costimulation of CD8alphabeta Tcells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2001, 2:255-260.
20. Groh V., Bruhl A., El-Gabalawy H., Nelson J.L., Spies T. Stimulation of Tcell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 2003, 100:9452-9457.
21. Groh V., Smythe K., Dai Z., Spies T. Fas-ligand-mediated paracrine Tcell regulation by the receptor NKG2D in tumor immunity. Nat. Immunol. 2006, 7:755-762.
22. Hober D., Sauter P. Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host. Nat. Rev. Endocrinol. 2010, 6:279-289.
23. Hyka-Nouspikel N., Lucian L., Murphy E., McClanahan T., Phillips J.H. DAP10 deficiency breaks the immune tolerance against transplantable syngeneic melanoma. J.Immunol. 2007, 179:3763-3771.
24. Jamieson A.M., Diefenbach A., McMahon C.W., Xiong N., Carlyle J.R., Raulet D.H. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 2002, 17:19-29.
25. Kassem S.A., Ariel I., Thornton P.S., Scheimberg I., Glaser B. Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes 2000, 49:1325-1333.
26. Kelly C.B., Blair L.A., Corbett J.A., Scarim A.L. Isolation of islets of Langerhans from rodent pancreas. Methods Mol. Med. 2003, 83:3-14.
27. Kurts C., Heath W.R., Carbone F.R., Allison J., Miller J.F., Kosaka H. Constitutive class I-restricted exogenous presentation of self antigens invivo. J.Exp. Med. 1996, 184:923-930.
28. Lennon G.P., Bettini M., Burton A.R., Vincent E., Arnold P.Y., Santamaria P., Vignali D.A. T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous event. Immunity 2009, 31:643-653.
29. Lobe C.G., Koop K.E., Kreppner W., Lomeli H., Gertsenstein M., Nagy A. Z/AP, a double reporter for cre-mediated recombination. Dev. Biol. 1999, 208:281-292.
30. Markiewicz M.A., Carayannopoulos L.N., Naidenko O.V., Matsui K., Burack W.R., Wise E.L., Fremont D.H., Allen P.M., Yokoyama W.M., Colonna M., Shaw A.S. Costimulation through NKG2D enhances murine CD8+ CTL function: similarities and differences between NKG2D and CD28 costimulation. J.Immunol. 2005, 175:2825-2833.
31. Masopust D., Vezys V., Usherwood E.J., Cauley L.S., Olson S., Marzo A.L., Ward R.L., Woodland D.L., Lefrançois L. Activated primary and memory CD8 Tcells migrate to nonlymphoid tissues regardless of site of activation or tissue of origin. J.Immunol. 2004, 172:4875-4882.
32. Meresse B., Chen Z., Ciszewski C., Tretiakova M., Bhagat G., Krausz T.N., Raulet D.H., Lanier L.L., Groh V., Spies T., et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 2004, 21:357-366.
33. Nakanishi Y., Lu B., Gerard C., Iwasaki A. CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help. Nature 2009, 462:510-513.
34. Nikitina-Zake L., Rajalingham R., Rumba I., Sanjeevi C.B. Killer cell immunoglobulin-like receptor genes in Latvian patients with type 1 diabetes mellitus and healthy controls. Ann. N Y Acad. Sci. 2004, 1037:161-169.
35. Novak A., Guo C., Yang W., Nagy A., Lobe C.G. Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision. Genesis 2000, 28:147-155.
36. Ogasawara K., Hamerman J.A., Ehrlich L.R., Bour-Jordan H., Santamaria P., Bluestone J.A., Lanier L.L. NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity 2004, 20:757-767.
37. Oppenheim D.E., Roberts S.J., Clarke S.L., Filler R., Lewis J.M., Tigelaar R.E., Girardi M., Hayday A.C. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity invivo and reduces tumor immunosurveillance. Nat. Immunol. 2005, 6:928-937.
38. Petrik J., Arany E., McDonald T.J., Hill D.J. Apoptosis in the pancreatic islet cells of the neonatal rat is associated with a reduced expression of insulin-like growth factor II that may act as a survival factor. Endocrinology 1998, 139:2994-3004.
39. Postic C., Shiota M., Niswender K.D., Jetton T.L., Chen Y., Moates J.M., Shelton K.D., Lindner J., Cherrington A.D., Magnuson M.A. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J.Biol. Chem. 1999, 274:305-315.
40. Raulet D.H. Roles of the NKG2D immunoreceptor and its ligands. Nat. Rev. Immunol. 2003, 3:781-790.
41. Rodacki M., Svoren B., Butty V., Besse W., Laffel L., Benoist C., Mathis D. Altered natural killer cells in type 1 diabetic patients. Diabetes 2007, 56:177-185.
42. Scaglia L., Cahill C.J., Finegood D.T., Bonner-Weir S. Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat. Endocrinology 1997, 138:1736-1741.
43. Strid J., Roberts S.J., Filler R.B., Lewis J.M., Kwong B.Y., Schpero W., Kaplan D.H., Hayday A.C., Girardi M. Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis. Nat. Immunol. 2008, 9:146-154.
44. Sutherland C.L., Chalupny N.J., Schooley K., VandenBos T., Kubin M., Cosman D. UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells. J.Immunol. 2002, 168:671-679.
45. Takada A., Yoshida S., Kajikawa M., Miyatake Y., Tomaru U., Sakai M., Chiba H., Maenaka K., Kohda D., Fugo K., Kasahara M. Two novel NKG2D ligands of the mouse H60 family with differential expression patterns and binding affinities to NKG2D. J.Immunol. 2008, 180:1678-1685.
46. Trudeau J.D., Dutz J.P., Arany E., Hill D.J., Fieldus W.E., Finegood D.T. Neonatal beta-cell apoptosis: a trigger for autoimmune diabetes?. Diabetes 2000, 49:1-7.
47. Turley S., Poirot L., Hattori M., Benoist C., Mathis D. Physiological beta cell death triggers priming of self-reactive Tcells by dendritic cells in a type-1 diabetes model. J.Exp. Med. 2003, 198:1527-1537.
48. Verneris M.R., Karami M., Baker J., Jayaswal A., Negrin R.S. Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ Tcells. Blood 2004, 103:3065-3072.
49. Wang J., Tsai S., Shameli A., Yamanouchi J., Alkemade G., Santamaria P. In situ recognition of autoantigen as an essential gatekeeper in autoimmune CD8+ Tcell inflammation. Proc. Natl. Acad. Sci. USA 2010, 107:9317-9322.
50. Whang M.I., Guerra N., Raulet D.H. Costimulation of dendritic epidermal gammadelta Tcells by a new NKG2D ligand expressed specifically in the skin. J.Immunol. 2009, 182:4557-4564.
51. Wiemann K., Mittrücker H.W., Feger U., Welte S.A., Yokoyama W.M., Spies T., Rammensee H.G., Steinle A. Systemic NKG2D down-regulation impairs NK and CD8 Tcell responses invivo. J.Immunol. 2005, 175:720-729.
52. Wu J., Song Y., Bakker A.B., Bauer S., Spies T., Lanier L.L., Phillips J.H. An activating immunoreceptor complex formed by NKG2D and DAP10. Science 1999, 285:730-732.
53. Zafirova B., Mandarić S., Antulov R., Krmpotić A., Jonsson H., Yokoyama W.M., Jonjić S., Polić B. Altered NK cell development and enhanced NK cell-mediated resistance to mouse cytomegalovirus in NKG2D-deficient mice. Immunity 2009, 31:270-282.